Assessment of cancer-specific microbiome signature of response to immune checkpoint inhibitors.

被引：2
|
作者：
Sarfaty, Michal
Desjardins, Christopher A.
Giardina, Paul
Bardhan, Kankana
Pandian, Swarna
Halley, Keith
Halvorsen, Elizabeth M.
Callahan, Margaret K.
Postow, Michael A.
Lee, Chung-Han
Kotecha, Ritesh
Kashani, Daniel
Ratna, Neha
Regazzi, Ashley Marie
Henn, Matthew R.
Hellmann, Matthew D.
Iyer, Gopa
Ford, Christopher B.
Peled, Jonathan U.
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Seres Therapeut, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.2574
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2574
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The gut microbiome and cancer response to immune checkpoint inhibitors
    Gazzaniga, Francesca S.
    Kasper, Dennis L.
    JOURNAL OF CLINICAL INVESTIGATION, 2025, 135 (03):
  • [2] Immune checkpoint inhibitors. A breakthrough in cancer therapy
    Cardenas-Oyarzo, Areli M.
    Bocchieri-Oyarce, Pamela A.
    Mendez-Laport, Cristian R.
    Zolezzi, Juan M.
    Rios, Juvenal A.
    REVISTA MEDICA DE CHILE, 2022, 150 (01) : 93 - 99
  • [3] Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies
    Das, Shaoli
    Camphausen, Kevin
    Shankavaram, Uma
    CANCERS, 2020, 12 (09) : 1 - 14
  • [4] Association of opioid use with response to immune checkpoint inhibitors.
    Weinfeld, Michael
    Wang, Heidy
    Liu, Li C.
    Pasquinelli, Mary
    Huber, Michael
    Feldman, Lawrence Eric
    Weinberg, Frank
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Nephrotoxicity in patients with cancer treated with immune checkpoint inhibitors.
    Papaiakovou, Evangelos Eleutherakis
    Kastritis, Efstathios
    Zagouri, Flora
    Grapsa, Dimitra
    Ntanassis-Stathopoulos, Ioannis
    Stefanou, Dimitra
    Evangelou, Georgios
    Kotteas, Ilias
    Dimopoulos, Meletios A.
    Syrigos, Konstantinos
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Immune profiling of metastatic uveal melanoma and response to immune checkpoint inhibitors.
    Shao, Yusra F.
    Baca, Yasmine
    Xiu, Joanne
    Vanderwalde, Ari M.
    In, Gino Kim
    Hoon, Dave S. B.
    Domingo-Musibay, Evidio
    Darabi, Sourat
    Eisenberg, Burton Larry
    Sato, Takami
    Gibney, Geoffrey Thomas
    Mamdani, Hirva
    Moser, Justin C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Impact of antibiotic use on response to treatment with immune checkpoint inhibitors.
    Khan, Uqba
    Pena, Cristian
    Brouwer, Julianna
    Hoffman, Katherine
    Choudhury, Arindam Roy
    Zhang, Chao
    Thakkar, Prashant
    Betel, Doron
    Sarkar, Sandipto
    Sonnenberg, Gregory
    Saxena, Ashish
    Shah, Manish A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [8] Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors
    Yang, Si
    Wu, Ying
    Deng, Yujiao
    Zhou, Linghui
    Yang, Pengtao
    Zheng, Yi
    Zhang, Dai
    Zhai, Zhen
    Li, Na
    Hao, Qian
    Song, Dingli
    Kang, Huafeng
    Dai, Zhijun
    ONCOIMMUNOLOGY, 2019, 8 (12):
  • [9] Delayed immune toxicities in patients with breast cancer receiving immune checkpoint inhibitors.
    Jacob, Saya
    Quandt, Zoe
    Melisko, Michelle E.
    Majure, Melanie
    Chien, Amy Jo
    Blaes, Anne Hudson
    Heditsian, Diane
    Esserman, Laura
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] The Emerging Role of the Gut Microbiome in the Cancer Response to Immune Checkpoint Inhibitors: A Narrative Review
    Araji, Ghada
    Maamari, Julian
    Ahmad, Fatima Ali
    Zareef, Rana
    Chaftari, Patrick
    Yeung, Sai-Ching Jim
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2022, 5 (01) : 13 - 25
12345